Have a personal or library account? Click to login
Emergency Angioembolization for Life-Threatening Hemorrhage in Wilms Tumor Cover

Emergency Angioembolization for Life-Threatening Hemorrhage in Wilms Tumor

Open Access
|Jan 2024

References

  1. Sauk S, Zuckerman DA. Renal artery embolization. Semin Intervent Radiol 2011;28:396-406.
  2. Sharma R, Kitchen BJ, Mody R, Chamdin A, Bruch S, Jasty R. A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor. Pediatr Surg Int 2013;29:533-5.
  3. Smith NP, Jesudason EC, McDowell HP, Rowlands P, Ashworth M, Losty PD. Emergent embolisation to control severe haematuria in Wilms’ tumour. Pediatr Surg Int 2005;21:313-5.
  4. Chitnis M, Chowdhary SK, Lazarus C. Preoperative angioembolisation for life-threatening haemorrhage from Wilms’ tumour: A case report. Pediatr Surg Int 2004;20:290-1.
  5. Van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwängler R, Verschuur AC, et al. Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol 2017;14:743-52.
  6. Pereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist 2004;9:561-70.
  7. Harrison MR, de Lorimier AA, Boswell WO. Preoperative angiographic embolization for large hemorrhagic Wilms’ tumor. J Pediatr Surg 1978;13:757-8.
  8. Ruff S, Bittman M, Lobko I, Williamson A, Dolgin S. Emergency embolization of a Wilms’ tumor for life-threatening hemorrhage prior to nephrectomy. J Pediatr Surg Case Rep 2014;2:280-3.
Language: English
Page range: 1 - 5
Submitted on: Oct 19, 2023
Accepted on: Dec 23, 2023
Published on: Jan 23, 2024
Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2024 Areej Salim, Sajid Ali, Muhammad Ali Sheikh, Tariq Latif, Islah Ud Din, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.